Skip to main content

Table 4 Baseline profile and outcome of patients with intervention prior to referral (group B)

From: Comparison of clinico-microbiological profile and treatment outcome of in-house and referred post cataract surgery endophthalmitis in a tertiary care center in South India

S no. Age (years) Prior intervention Presenting BCVA Our intervention Organism Sensitivity Final BCVA
1 70 IOAB LP PPV + 2x IOAB P. aeroginosa Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin
Resistant to chloramphenicol
LP
2 10 2x IOAB LP PPV + 2x IOAB Streptococcus pyogenes Sensitive to vanomycin, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin
Resistant to amikacin
 
3 64 AC wash + IOAB LP Vitreous biopsy + 5x IOAB P. aeruginosa Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, and ofloxacin
Resistant to tobramycin
LP
4 62 Vitreous biosy + IOAB 6/36 PPV + 2x IOAB R. radiobacter Sensitive to amikacin, ceftazidime, gatifloxacin, moxifloxacin, cirprofloxacin, ofloxacin
Resistant to chloramphenicol
6/36
5 55 2x IOAB 6/36 PPV + IOAB + 2x Intravitreal Amphoterecin B C. pelliculosa 6/15
  1. IOAB intraocular (antibacterial) antibiotic injection